PRICE T ROWE ASSOCIATES INC /MD/
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 80255
BALTIMORE, MD
Position in RARE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$45,293,568
+$28,447,486 QoQ
Shares Held
1,356,501
+68.7% QoQ
Ownership
1.38%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. RARE ranks #71 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in RARE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,293,568 | 1,356,501 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,846,082 | 804,109 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $35,750,418 | 1,554,366 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $69,490,033 | 2,310,174 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $104,944,704 | 2,886,268 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $116,557,889 | 3,218,942 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $105,697,634 | 2,512,423 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $170,463,729 | 3,068,654 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $122,969,473 | 2,991,958 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $166,630,679 | 3,568,873 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $164,916,737 | 3,448,698 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $112,659,704 | 3,160,160 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $166,759,580 | 3,614,992 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $142,104,815 | 3,543,761 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $189,785,655 | 4,096,388 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $196,985,547 | 4,756,956 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $643,144,106 | 10,780,156 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $863,073,159 | 11,884,786 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $969,144,734 | 11,525,089 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,033,491,358 | 11,459,046 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,048,775,054 | 10,999,214 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,215,089,553 | 10,671,786 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,311,000,207 | 9,470,492 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $686,182,036 | 8,348,729 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $599,682,781 | 7,666,617 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $209,212,961 | 4,708,822 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||